Medicine & Health

Researchers at WashU Medicine found that a small population of immune cells in the mouse intestine prevents allergic responses to food, suggesting that targeting such cells therapeutically could potentially lead to a new treatment for allergies.

Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an inflammatory illness precisely when it was most needed.

Aaron Y. Lee, MD, a leader in applying artificial intelligence to ophthalmology research and patient care, will head the John. F. Hardesty, MD, Department of Ophthalmology & Visual Sciences at WashU Medicine.

A clinical trial led by Richard S. Hotchkiss, MD, a professor of anesthesiology at WashU Medicine, has found that treating critically ill COVID-19 patients with an immune-boosting protein reduces life-threatening secondary infections, a major cause of death in such patients.

Steven Bassnett, a national leader in vision research, has been installed as the inaugural Grace Nelson Lacy Distinguished Professor in Ophthalmology at WashU Medicine.

Seven WashU faculty members are among the 471 new fellows selected by the American Association for the Advancement of Science.

Biomedical researchers at Washington University have decoded how mechanical forces drive cell behavior in fibrosis.

Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.

A $2.2 million National Institutes of Health (NIH) grant will fund research in the McKelvey School of Engineering to explore how epithelial cells sense their environments and acquire mechanical memories.

According to a new study by WashU Medicine researchers, male and female rats with a chronic pain condition release different amounts of dopamine when given fentanyl because of sex hormones. The findings might help explain why men have higher rates of opioid use and overdose deaths.